全球全基因組擴增市場規模、佔有率、趨勢和成長分析報告（2026-2034）

全基因組擴增市場預計將從 2025 年的 45.8 億美元成長到 2034 年的 112.2 億美元，2026 年至 2034 年的複合年成長率為 10.46%。

受基因組學和分子生物學進步的推動，全球全基因組擴增（WGA）市場正經歷快速成長。 WGA技術能夠從有限的DNA樣本中擴增整個基因組，使其在研究、診斷和法醫學發揮至關重要的作用。對基因分析和個人化醫療日益成長的需求是推動市場擴張的主要因素。

主要的促進因素包括次世代定序（NGS）技術的廣泛應用和基因組研究投入的增加。全基因組擴增（WGA）在癌症研究、產前檢測和單細胞分析等應用領域中發揮著至關重要的作用。此外，人們對精準醫療和疾病早期檢測的日益關注也推動了對先進基因組工具和技術的需求。

隨著擴增技術的不斷創新以及與數位健康平台的融合，市場預計將持續成長。在新興市場，不斷擴展的研究基礎設施有望創造巨大的成長機會。然而，高成本和技術複雜性可能會阻礙其廣泛應用。儘管面臨這些挑戰，在基因組學持續進步的推動下，WGA市場依然蘊藏著巨大的潛力。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球全基因組擴增市場：依產品類型分類

• 市場分析、洞察與預測
• 成套工具
• 試劑
• 裝置

第5章：全球全基因組擴增市場：依應用領域分類

• 市場分析、洞察與預測
• 診斷
• 藥物發現與開發
• 調查
• 法醫學
• 其他

第6章：全球全基因組擴增市場：依最終用戶分類

• 市場分析、洞察與預測
• 醫院和診所
• 製藥和生物技術公司
• 研究機構
• 其他

第7章：全球全基因組擴增市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Thermo Fisher Scientific Inc
  • Qiagen NV
  • Illumina Inc
  • Merck KGaA
  • GE Healthcare
  • Agilent Technologies Inc
  • Bio-Rad Laboratories Inc
  • New England Biolabs Inc
  • Takara Bio Inc
  • LGC Limited
  • Oxford Nanopore Technologies Ltd

The Whole Genome Amplification Market size is expected to reach USD 11.22 Billion in 2034 from USD 4.58 Billion (2025) growing at a CAGR of 10.46% during 2026-2034.

The Global Whole Genome Amplification (WGA) Market is experiencing rapid growth driven by advancements in genomics and molecular biology. WGA techniques enable the amplification of entire genomes from limited DNA samples, making them essential in research, diagnostics, and forensic applications. The increasing demand for genetic analysis and personalized medicine is a key factor fueling market expansion.

Key drivers include the rising adoption of next-generation sequencing (NGS) technologies and increasing investments in genomic research. WGA plays a critical role in applications such as cancer research, prenatal testing, and single-cell analysis. Additionally, the growing focus on precision medicine and early disease detection is driving demand for advanced genomic tools and technologies.

Looking ahead, the market is expected to grow with ongoing innovations in amplification technologies and increasing integration with digital health platforms. Emerging markets are likely to offer significant growth opportunities due to expanding research infrastructure. However, high costs and technical complexities may limit adoption. Despite these challenges, the WGA market holds strong potential driven by continuous advancements in genomics.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

• Kits
• Reagents
• Instruments

By Application

• Diagnostics
• Drug Discovery And Development
• Research
• Forensics
• Others

By End-User

• Hospitals And Clinics
• Pharmaceutical And Biotechnology Companies
• Research Institutes
• Others

COMPANIES PROFILED

• Thermo Fisher Scientific Inc, Qiagen NV, Illumina Inc, Merck KGaA, GE Healthcare, Agilent Technologies Inc, BioRad Laboratories Inc, New England Biolabs Inc, Takara Bio Inc, LGC Limited, Oxford Nanopore Technologies Ltd
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL WHOLE GENOME AMPLIFICATION MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. Kits Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL WHOLE GENOME AMPLIFICATION MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Drug Discovery And Development Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Research Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Forensics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL WHOLE GENOME AMPLIFICATION MARKET: BY END-USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-user
• 6.2. Hospitals And Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Pharmaceutical And Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL WHOLE GENOME AMPLIFICATION MARKET: BY REGION 2022-2034 (USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product Type
  • 7.2.2 By Application
  • 7.2.3 By End-user
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product Type
  • 7.3.2 By Application
  • 7.3.3 By End-user
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product Type
  • 7.4.2 By Application
  • 7.4.3 By End-user
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product Type
  • 7.5.2 By Application
  • 7.5.3 By End-user
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product Type
  • 7.6.2 By Application
  • 7.6.3 By End-user
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL WHOLE GENOME AMPLIFICATION INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Thermo Fisher Scientific Inc
  • 9.2.2 Qiagen N.V
  • 9.2.3 Illumina Inc
  • 9.2.4 Merck KGaA
  • 9.2.5 GE Healthcare
  • 9.2.6 Agilent Technologies Inc
  • 9.2.7 Bio-Rad Laboratories Inc
  • 9.2.8 New England Biolabs Inc
  • 9.2.9 Takara Bio Inc
  • 9.2.10 LGC Limited
  • 9.2.11 Oxford Nanopore Technologies Ltd